Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

Panelists discuss how CT-155, a 16-week interactive digital application, met its primary end point in clinical trials by ...

A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

GRIN2A gene mutations emerge as single-gene cause of childhood schizophrenia, anxiety, and mood disorders, potentially ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...